Related Experiment Video
Updated: May 15, 2026

14:58
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
Published on: March 5, 2022
StRAP: an integrated resource for profiling high-throughput cancer genomic data from stress response studies
Seth Johnson1, Biju Issac, Shuping Zhao
1Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Plos One
|January 4, 2013
Summary
The Stress Response Array Profiler (StRAP) is a new open-source tool that integrates and analyzes cancer genomic data. It aids in identifying cancer biomarkers and predicting treatment response using a systems biology approach.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- DNA microarray technology has advanced cancer profiling for biomarker discovery and treatment response prediction.
- Integrating and querying diverse cancer genomic data presents significant challenges.
Purpose of the Study:
- To introduce the Stress Response Array Profiler (StRAP), an open-source web resource.
- To facilitate storage, profiling, visualization, and sharing of cancer genomic data.
- To enable comparative analysis and cross-validation of multiple cancer profiling studies.
Main Methods:
- Developed StRAP, a web-based resource for cancer genomic data.
- Integrated multi-cancer microarray data, focusing on radiotherapy studies.
- Employed a systems biology approach for data integration and analysis.
- Provided interactive visualization tools for data exploration and query results.
Main Results:
- StRAP offers a comprehensive platform for comparative gene expression analysis.
- The resource supports the integration and comparison of multiple cancer profiling studies.
- User-friendly visualization tools enhance data accessibility and interpretation.
Conclusions:
- StRAP addresses the challenge of compiling and querying complex cancer genomic data.
- This open-source resource promotes a systems biology approach for cancer research.
- StRAP is freely accessible and platform-independent, supporting biomarker discovery and treatment response prediction.
